ORIENT BIO Inc. (002630.KS)
KRW 967.0
(-14.65%)
KRW 967.0
(-14.65%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 28 Billion | 28.81 Billion | 26.27 Billion | 52.02 Billion | 37.69 Billion | 30.37 Billion |
| Cost of Revenue | 18.42 Billion | 18.99 Billion | 17.26 Billion | 32.79 Billion | 30.49 Billion | 27.36 Billion |
| Gross Profit | 9.58 Billion | 9.82 Billion | 9.01 Billion | 19.22 Billion | 7.19 Billion | 3.01 Billion |
| Operating Expenses | 10.23 Billion | 8.37 Billion | 12.79 Billion | 17.36 Billion | 18.44 Billion | 12.24 Billion |
| Selling, General and Administrative Expenses | 3.78 Billion | 3 Billion | 2.5 Billion | 3.48 Billion | 4.83 Billion | 6.4 Billion |
| Research and Development Expenses | 1.94 Billion | 1.8 Billion | 2.59 Billion | 2.64 Billion | 1.4 Billion | 655.27 Million |
| Other Expenses | 4.49 Billion | -245.35 Million | 194.38 Million | 27.78 Million | 120.94 Million | 16.32 Million |
| Cost and Expenses | 28.65 Billion | 27.36 Billion | 30.05 Billion | 50.16 Billion | 48.94 Billion | 39.6 Billion |
| Operating Income | 1.45 Billion | 1.45 Billion | -3.78 Billion | 1.85 Billion | -11.24 Billion | -10.12 Billion |
| Interest Expense | 56.9 Million | 252.28 Million | 432.88 Million | 559.69 Million | 439.25 Million | 3.44 Billion |
| Income Tax Expense | - | -167.02 Million | 69.12 Million | -34.44 Million | 1.66 Billion | 5.25 Billion |
| Earnings before Tax | 12.87 Billion | -12.59 Billion | -3.36 Billion | -15.66 Billion | -11.64 Billion | -13.18 Billion |
| Net Income | 12.87 Billion | -12.42 Billion | 34.19 Billion | -15.63 Billion | -10.88 Billion | -19.5 Billion |
| Earnings Per Share Basic | 108.55 | -104.78 | -13.15 | -138.07 | -105.42 | -251.44 |
| Earnings Per Share Diluted | 108.55 | -104.78 | -13.15 | -138.07 | -105.42 | -251.44 |
| Weighted Average Shares Outstanding | 118.56 Million | 118.56 Million | 118.58 Million | 113.22 Million | 103.21 Million | 77.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 118.56 Million | 118.56 Million | 118.58 Million | 113.22 Million | 103.21 Million | 77.57 Million |
| Gross Margin | 0.34 | 0.34 | 0.34 | 0.37 | 0.19 | 0.10 |
| EBIT Margin | 0.56 | 0.23 | 0.06 | 0.05 | -0.12 | -0.07 |
| Profit Margin | 0.46 | -0.43 | 1.30 | -0.30 | -0.29 | -0.64 |
| EBITDA | 15.66 Billion | -6.1 Billion | 1.28 Billion | -13.63 Billion | -8.17 Billion | -1.66 Billion |
| Earnings Before Tax Margin | 0.05 | 0.05 | -0.14 | 0.04 | -0.30 | -0.33 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 7.38 Billion | 5.96 Billion | 28.81 Billion | 8.18 Billion | 6.41 Billion | 7.02 Billion |
| Cost of Revenue | 5.32 Billion | 4.01 Billion | 18.99 Billion | 5.69 Billion | 3.62 Billion | 4.27 Billion |
| Gross Profit | 2.05 Billion | 1.94 Billion | 9.82 Billion | 2.49 Billion | 2.78 Billion | 2.74 Billion |
| Operating Expenses | 1.68 Billion | 2.35 Billion | 8.37 Billion | 2.39 Billion | 2.79 Billion | 2.05 Billion |
| Selling, General and Administrative Expenses | 1.49 Billion | 1.52 Billion | - | 1.04 Billion | 1.25 Billion | 720.03 Million |
| Research and Development Expenses | 93.95 Million | 482.58 Million | - | 351.09 Million | 1.11 Billion | 343.91 Million |
| Other Expenses | -95.27 Million | -6.94 Billion | -28.37 Billion | 586.56 Million | -363.17 Million | 16.13 Million |
| Cost and Expenses | 7.01 Billion | 6.94 Billion | 28.37 Billion | 8.08 Billion | 6.41 Billion | 6.33 Billion |
| Operating Income | 372.99 Million | -409.99 Million | 1.45 Billion | -497.74 Million | -4.6 Million | 690.09 Million |
| Interest Expense | 59.32 Million | 17.95 Million | 252.28 Million | 13.15 Million | 6.62 Million | 7.81 Million |
| Income Tax Expense | 43.59 Million | -163.71 Million | -167.02 Million | 7.72 Million | 22.96 Million | -91.11 Million |
| Earnings before Tax | -6.74 Billion | 347.84 Million | -12.59 Billion | 221.03 Million | -627.03 Million | 2.22 Billion |
| Net Income | -6.78 Billion | 6.53 Billion | 8.41 Billion | 213.31 Million | -649.99 Million | 2.31 Billion |
| Earnings Per Share Basic | -57.22 | 55.08 | - | 1.80 | -5.48 | 19.54 |
| Earnings Per Share Diluted | -57.22 | 55.08 | - | 1.80 | -5.48 | 19.54 |
| Weighted Average Shares Outstanding | 118.56 Million | 118.57 Million | 118.57 Million | 118.56 Million | 118.56 Million | 118.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 118.56 Million | 118.57 Million | 118.57 Million | 118.56 Million | 118.56 Million | 118.56 Million |
| Gross Margin | 0.28 | 0.33 | 0.34 | 0.30 | 0.43 | 0.39 |
| EBIT Margin | 0.12 | -0.09 | - | 0.06 | 0.19 | 0.42 |
| Profit Margin | -0.92 | 1.10 | 0.29 | 0.03 | -0.10 | 0.33 |
| EBITDA | 853.79 Million | -558.41 Million | - | 511.24 Million | 1.22 Billion | 2.97 Billion |
| Earnings Before Tax Margin | 0.05 | -0.07 | 0.05 | -0.06 | -0.00 | 0.10 |
3380
GTLB
002165
EQNR
SMOP
FICO